Blandt lamivudin- refraktoriske patienter med baseline HBV DNA < 107 log10 kopier/ ml opnåede 64% (9/ 14) HBV DNA < 300 kopier/ ml i Uge 48.
Among lamivudine-refractory patients with baseline HBV DNA < 107 log10 copies/ ml, 64% (9/ 14) achieved HBV DNA < 300 copies/ ml at Week 48.